Period | Date | Adjusted Actuals EPS | GAAP EPS |
---|---|---|---|
Q3 2022 | 2022-11-04 | Future report Set alerts | |
Q2 2022 | 2022-08-03 | -0.11 | -0.11 |
Q1 2022 | 2022-05-04 | -0.08 | -0.08 |
Q4 2021 | 2022-03-01 | 0.04 | 0.04 |
Q3 2021 | 2021-11-03 | -0.03 | -0.03 |
Q2 2021 | 2021-08-05 | 0.02 | 0.02 |
Q1 2021 | 2021-04-29 | 0.00 | 0.00 |
Q4 2020 | 2021-02-25 | 0.01 | 0.01 |
Q3 2020 | 2020-11-04 | 0.00 | 0.00 |
Q2 2020 | 2020-08-04 | 0.01 | 0.01 |
2016-07-07 | Reiterated Rating | Jefferies Group | Buy | $3.50 |
2016-06-08 | Reiterated Rating | Jefferies Group | Buy | |
2016-05-31 | Reiterated Rating | Jefferies Group | Buy | |
2016-05-12 | Initiated Coverage | Jefferies Group | Buy | $3.50 |
2016-05-09 | Reiterated Rating | HC Wainwright | Buy | $10.00 |
2016-02-26 | Reiterated Rating | HC Wainwright | Buy | $10.00 |
2015-10-13 | Reiterated Rating | Jefferies Group | Buy | $3.50 |
2015-08-11 | Reiterated Rating | Oppenheimer | Market Perform | |
2015-08-11 | Reiterated Rating | Oppenheimer Holdings Inc. | Market Perform | |
2015-06-02 | Reiterated Rating | Oppenheimer | Sector Perform | |
2015-03-12 | Upgrade | HC Wainwright | Neutral to Buy | $2.50 to $10.00 |
2015-02-18 | Upgrade | SunTrust | Neutral to Buy | |
2015-02-18 | Upgrade | SunTrust Banks Inc. | Neutral to Buy | |
2014-09-17 | Reiterated Rating | Jefferies Group | Reduce | |
2014-08-08 | Reiterated Rating | Goldman Sachs | Neutral | |
2014-08-08 | Reiterated Rating | Goldman Sachs Group Inc. | Neutral | |
2014-05-12 | Reiterated Rating | MKM Partners | Fair Value | $2.00 to $1.50 |
2014-05-12 | Reiterated Rating | Aegis | Hold | |
2014-05-09 | Downgrade | Citigroup Inc. | Buy to Neutral | |
2014-04-01 | Reiterated Rating | MKM Partners | Neutral | $1.50 to $2.00 |
2014-04-01 | Boost Price Target | Jefferies Group | $3.00 to $3.50 | |
2014-04-01 | Reiterated Rating | Aegis | Hold | |
2014-02-28 | Reiterated Rating | Aegis | Hold | |
2014-02-24 | Lower Price Target | MKM Partners | Neutral | $2.50 to $1.75 |
2014-01-16 | Downgrade | MKM Partners | Buy to Neutral | $2.50 |
2013-11-19 | Reiterated Rating | Canaccord Genuity | Hold | $1.60 |
2013-11-19 | Lower Price Target | Roth Capital | Buy | $5.00 to $4.00 |
2013-11-11 | Reiterated Rating | Aegis | Hold | |
2013-11-08 | Lower Price Target | MKM Partners | Buy | $5.00 to $2.50 |
2013-11-08 | Lower Price Target | Canaccord Genuity | Hold | $3.00 to $1.60 |
2013-11-08 | Upgrade | Citigroup Inc. | Neutral to Buy | $1.36 to $2.50 |
2013-10-30 | Reiterated Rating | Aegis | Hold | |
2013-10-30 | Downgrade | Leerink Swann | Outperform to Market Perform | $6.00 to $2.00 |
2013-10-30 | Initiated Coverage | FBR & Co. | Market Perform | $2.00 |
2013-10-18 | Downgrade | Citigroup Inc. | Buy to Neutral | $11.00 to $2.50 |
2013-10-17 | Lower Price Target | MKM Partners | Buy | $9.00 to $5.00 |
2013-10-17 | Downgrade | Aegis Capital | Buy to Hold | |
2013-10-17 | Lower Price Target | Roth Capital | Buy | $15.00 to $5.00 |
2013-10-17 | Downgrade | HC Wainwright | Buy to Neutral | |
2013-10-17 | Downgrade | Canaccord Genuity | Buy to Hold | $10.00 to $3.00 |
2013-10-17 | Downgrade | Jefferies Group | Buy | $20.00 to $4.00 |
2013-10-17 | Downgrade | JPMorgan Chase & Co. | Overweight to Neutral | |
2013-10-16 | Lower Price Target | Leerink Swann | $6.00 | |
2013-10-16 | Downgrade | Aegis | Buy to Hold | $30.00 |
2013-10-16 | Downgrade | SunTrust | Buy to Neutral | $15.00 to $8.00 |
2013-10-14 | Lower Price Target | Oppenheimer | Market Perform | $7.00 to $6.00 |
2013-10-14 | Reiterated Rating | Aegis | Buy to Buy | $30.00 |
2013-10-14 | Reiterated Rating | Leerink Swann | Outperform | |
2013-10-10 | Reiterated Rating | Jefferies Group | Buy to Positive | $4.00 |
2013-10-09 | Boost Price Target | Goldman Sachs | Neutral | $3.00 to $9.00 |
2013-09-17 | Initiated Coverage | Goldman Sachs | Neutral | |
2013-03-20 | Initiated | Chardan Capital Markets | Hold | $8.50 |
2012-12-07 | Reiterated | Aegis Capital | Buy | $25 to $35 |
2011-07-12 | Initiated | MKM Partners | Buy | $23 |
2011-04-18 | Reiterated | Canaccord Genuity | Buy | $11 to $18 |
2010-12-29 | Reiterated | Wedbush | Outperform | $7 to $10 |
2010-07-20 | Initiated | Wedbush | Outperform | $5 |
2009-02-03 | Initiated | Rodman & Renshaw | Mkt Outperform | $3.50 |
2008-11-06 | Initiated | Rodman & Renshaw | Mkt Outperform | $3.50 |
2016-07-07 | Reiterated Rating | Jefferies Group | Buy | $3.50 |
2016-06-08 | Reiterated Rating | Jefferies Group | Buy | |
2016-05-31 | Reiterated Rating | Jefferies Group | Buy | |
2016-05-12 | Initiated Coverage | Jefferies Group | Buy | $3.50 |
2016-05-09 | Reiterated Rating | HC Wainwright | Buy | $10.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In AMRN 127 funds of 2213 total. Show all
Fund name | Ticker shares |
---|---|
Sarissa Capital Management LP | 24.00M |
Stonepine Capital Management, LLC | 8.55M |
OPPENHEIMER FUNDS INC | 7.85M |
venBio Select Advisor LLC | 6.00M |
DG Capital Management, LLC | 5.81M |
MORGAN STANLEY | 5.65M |
BAKER BROS. ADVISORS LP | 5.38M |
BlackRock Fund Advisors | 3.50M |
Bluefin Trading, LLC | 2.76M |
TWO SIGMA INVESTMENTS LLC | 2.02M |
13D Management LLC | 1.79M |
AMERIPRISE FINANCIAL INC | 1.32M |
CITADEL ADVISORS LLC | 1.29M |
Broadfin Capital, LLC | 1.05M |
UBS Group AG | 0.87M |